With this issue we welcome three members to the distinguished editorial advisory board that has guided Contemporary OB/GYN since its inception.
Yalda Afshar, MD, PhD; Christine Isaacs, MD; and Laura Riley, MD begin their time in lending expertise to the content in these pages and online. You can read more about each remarkable scientist here.
We hope you also will find the content in this issue rich and informative. The Society for Maternal-Fetal Medicine (SMFM) shares its Consult Series #50 on Activity Restriction in obstetric management. Editor-in-Chief Catherine Y. Spong, MD, dedicates her editorial to the topic with an endorsement to put activity restriction to bed – her pun fully intended – as research now is available to provide guidance for practitioners recommending against its routine use.
Practitioners continue to navigate health care in a pandemic, conducting much patient communication virtually. Four doctors from Yale—Linda L. Fan, MD, FACOG; Shefali R. Pathy, MD, MPH; Julia Cron, MD; and Sangini S. Sheth, MD, MPH—offer their guidance on managing the Well Woman visit via telehealth.
In the first article of a two-part series, Amanda Kallen, MD, and Sandra Ann Carson, MD, offer a thorough guide to diagnosing an infertile couple. Watch for next month’s article as well, where they provide a guide for treatment.
Ronald J. Wapner, MD, makes a case for improved carrier screening. Ideally, women of reproductive age would be offered carrier screening before conception to maximize the subsequent reproductive options for carrier couples, he says.
Please let us know what you think of this content; reader feedback is invited by emailing Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More